Glaucoma management is undergoing a significant transformation. For decades, the cornerstone of treatment has been daily bimatoprost eye drops. These drops are effective but present a persistent challenge: patient adherence. The requirement for strict, lifelong daily application is difficult for many. Missed doses lead to uncontrolled intraocular pressure (IOP) and potential vision loss. A novel solution

Continue Reading